Laminopathies

Journal of Pathology

Volumn 204, Issue 4, 2004, Pages 478-488

  Broers, Jos L V ^a,b   Hutchison, Chris J ^c   Ramaekers, Frans C S ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Chromatin association; Emerin; Mechanical weakness; Nuclear lamina; pRb

Indexed keywords

INTERMEDIATE FILAMENT PROTEIN; LAMIN; MEMBRANE PROTEIN;

CELL NUCLEUS; CELL NUCLEUS MEMBRANE; GENE MUTATION; GENETIC DISORDER; HUMAN; INTERMEDIATE FILAMENT; MUSCLE DISEASE; NONHUMAN; NUCLEAR LAMINA; NUCLEAR PORE; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS FAT DISORDER; TRANSCRIPTION REGULATION;

ADIPOSE TISSUE; CHROMATIN; CONNECTIVE TISSUE DISEASES; CYTOSKELETON; DNA; GENE EXPRESSION; HUMANS; INTERPHASE; LAMINS; MITOSIS; MUSCULAR DISEASES; MUTATION; NUCLEAR LAMINA; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 7944221826     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1655     Document Type: Review

References (90)

1. Gerace L, Blobel G. Nuclear lamina and the structural organization of the nuclear envelope. Cold Spring Harbor Symp Quant Biol 1982; 46: 967-978.
2. Aebi U, Cohn J, Buhle L, Gerace L. The nuclear lamina is a meshwork of intermediate filaments. Nature 1986; 323: 560-564.
3. Broers JLV, Machiels BM, van Eys GJJ, et al. Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. J Cell Sci 1999; 112: 3463-3475.
4. Gruenbaum Y, Wilson KL, Harel A, Goldberg M, Cohen M. Nuclear lamins - structural proteins with fundamental functions. J Struct Biol 2000; 129: 313-323.
5. Broers JL, Machiels BM, Kuijpers HJ, et al. A- and B-type lamins are differentially expressed in normal human tissues. Histochem Cell Biol 1997; 107: 505-517.
6. Röber RA, Weber, K, Osborn, M. Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 1989; 105: 365-378.
7. Furukawa K, Kondo T. Identification of the lamina-associated-polypeptide-2-binding domain of B-type lamin. Eur J Biochem 1998; 251: 729-733.
8. Lin F, Worman HJ. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 1993; 268: 16 321-16 326.
9. Machiels BM, Zorenc AHG, Endert JM, et al. An alternative splicing product of the lamin A/C gene lacks exon 10. J Biol Chem 1996; 271: 9249-9253.
10. Bridger JM, Kill I, O'Farrell M, Hutchison CJ. Internal lamin structure within G1 nuclei of human dermal fibroblasts. J Cell Sci 1993; 104: 297-306.
11. Kennedy BK, Barbie DA, Classon M, Dyson N, Harlow E. Nuclear organization of DNA replication in primary mammalian cells. Genes Dev 2000; 14: 2855-2868.
12. Moir RD, Montag-Lowy M, Goldman RD. Dynamic properties of nuclear lantins: lamin B is associated with sites of DNA replication. J Cell Biol 1994; 125: 1201-1212.
13. Fricker M, Hollinshead M, White N, Vaux D. Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane bound invaginations of the nuclear envelope. J Cell Biol 1997; 136: 531-544.
14. Liu J, Ben-Shahar TR, Riemer D, et al. Essential roles for Caenorhabditis elegans lamin gene in nuclear organization, cell cycle progression, and spatial organization of nuclear pore complexes. Mol Biol Cell 2000; 11: 3937-3947.
15. Moir RD, Yoon M, Khuon S, Goldman RD. Nuclear lamins A and B1: different pathways of assembly during nuclear envelope formation in living cells. J Cell Biol 2000; 151: 1155-1168.
16. Glass CA, Glass JR, Taniura H, Hasel KW, Blevitt JM, Gerace L. The alpha-helical rod domain of human lamins A and C contains a chromatin binding site. EMBO J 1993; 12: 4413-4424.
17. Taniura H, Glass C, Gerace L. A chromatin binding site in the tail domain of nuclear lamins that interacts with core histones. J Cell Biol 1995; 131: 33-44.
18. Wilson KL, Zastrow MS, Lee KK. Lamins and disease: insights into nuclear infrastructure. Cell 2001; 104: 647-650.
19. Moir RD, Spann TP, Goldman RD. The dynamic properties and possible functions of nuclear lamins. Int Rev Cytol 1995; 162B 141-182.
20. Cohen M, Lee KK, Wilson KL, Gruenbaum Y. Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem Sci 2001; 26: 41-47.
21. Holaska JM, Wilson KL, Mansharamani M. The nuclear envelope, lamins and nuclear assembly. Curr Opin Cell Biol 2002; 14: 357-364.
22. Jagatheesan G, Thanumalayan S, Muralikrishna B, Rangaraj N, Karande AA, Parnaik VK. Colocalization of intranuclear lamin foci with RNA splicing factors. J Cell Sci 1999; 112: 4651-4661.
23. Dechat T, Vlcek S, Foisner R. Lamina-associated polypeptide 2 isoforms and related proteins in cell cycle-dependent nuclear structure dynamics. J Struct Biol 2000; 129: 335-345.
24. Mislow J, Holaska J, Kim M, et al. Nesprin-1alpha self-associates and binds directly to emerin and lamin A in vitro. FEBS Lett 2002; 525: 135.
25. Mounkes L, Kozlov S, Burke B, Stewart CL. The laminopathies: nuclear structure meets disease. Curr Opin Genet Dev 2003; 13 223-230.
26. Hutchison CJ, Alvarez-Reyes M, Vaughan OA. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J Cell Sci 2001; 114: 9-19.
27. Ludérus MEE, de Graaf A, Mattia E, et al. Binding of matrix attachment regions to lamin B1. Cell 1992; 70: 949-959.
28. Sullivan T, Escalante-Alcalde D, Bhatt H, et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999; 147: 913-920.
29. Spann TP, Moir RD, Goldman AE, Stick R, Goldman RD. Disruption of nuclear lamin organization alters the distribution of replication factors and inhibits DNA synthesis. J Cell Biol 1997; 136: 1201-1212.
30. Dimitrova DS, Berezney R. The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells. J Cell Sci 2002; 115: 4037-4051.
31. Pugh GE, Coates PJ, Lane EB, Raymond Y, Quinlan RA. Distinct nuclear assembly pathways for lamins A and C lead to their increase during quiescence in Swiss 3T3 cells. J Cell Sci 1997; 110: 2483-2493.
32. Broers JLV, Ramackers FCS. Dynamics of nuclear lamina assembly and disassembly. In The Nuclear Envelope, Evans DE, Bryant JA, Hutchison C, (eds). Garland/Bios Scientific Publishers: Abingdon, 2004; 177-192.
33. Sasseville AMJ, Raymond Y. Lamin A precursor is localized to intranuclear foci. J Cell Sci 1995; 108: 273-285.
34. Sinensky M, Fantle K, Trujillo M, McLain T, Kupfer A, Dalton M. The processing pathway of prelamin A. J Cell Sci 1994; 107 61-67.
35. Ellis DJ, Jenkins H, Whitfield WG, Hutchison CJ. GST-lamin fusion proteins act as dominant negative mutants in Xenopus egg extract and reveal the function of the lamina in DNA replication. J Cell Sci 1997; 110: 2507-2518.
36. Spann TP, Goldman AE, Wang C, Huang S, Goldman RD. Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription. J Cell Biol 2002; 156: 603-638.
37. Muralikrishna B, Dhawan J, Rangaraj N, Parnaik VK. Distinct changes in intranuclear lamin A/C organization during myoblast differentiation. J Cell Sci 2001; 114: 4001-4011.
38. Dagenais A, LeMyre A, Bibor-Hardy V. Differential transport and integration into the nuclear lamina for lamins A, B, and C. Biochem Cell Biol 1990; 68: 827-831.
39. Daigle N, Beaudouin J, Hartnell L, et al. Nuclear pore complexes form immobile networks and have a very low turnover in live mammalian cells. J Cell Biol 2001; 154: 71-84.
40. Peter M, Nakagawa J, Dorée M, Labbé JC, Nigg EA. In vitro disassembly of the nuclear lamina and M phase-specific phosphorylation of lamins by cdc2 kinase. Cell 1990; 61: 591-602.
41. Ward GE, Kirschner MW. Identification of cell-cycle regulated phosphorylation sites on nuclear lamin C. Cell 1990; 61: 561-577.
42. Nigg EA. Assembly and cell cycle dynamics of the nuclear lamina. Semin Cell Biol 1992; 3: 245-253.
43. Beaudouin J, Gerlich D, Daigle N, Eils R, Ellenberg J. Nuclear envelope breakdown proceeds by microtubule-induced tearing of the lamina. Cell 2002; 108: 83-96.
44. Chaudhary N, Courvalin J-C. Stepwise reassembly of the nuclear envelope at the end of mitosis. J Cell Biol 1993; 122 295-306.
45. Foisner R. Dynamic organisation of intermediate filaments and associated proteins during the cell cycle. Bioessays 1997; 19 297-305.
46. Yang L, Guan T, Gerace L. Integral membrane proteins of the nuclear envelope are dispersed throughout the endoplasmic reticulum during mitosis. J Cell Biol 1997; 137: 1199-1210.
47. Lopez-Soler RI, Moir RD, Spann TP, Stick R, Goldman RD. A role for nuclear lamins in nuclear envelope assembly. J Cell Biol 2001; 15: 61-70.
48. Fidzianska A, Toniolo D, Hausmaowa-Petrusewicz I. Ultrastructural abnormality of sarcolemmal nuclei in Emery-Dreifuss muscular dystrophy (EDMD). J Neurol Sci 1998; 159: 88-93.
49. Sullivan T, Escalante-Alcalde D, Bhatt H, et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999; 147: 913-920.
50. Wilson KL, Zastro MS, Lee KK. Lamins and disease: insights into nuclear infrastructure. Cell 2001; 104: 647-650.
51. Cohen M, Lee KK, Wilson KL, Gruenbaum Y. Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. TIBS 2001; 26: 41-48.
52. Worman HJ, Courvalin JC. How do mutations in lamins A and C cause disease? J Clin Invest 2004; 113: 349-351.
53. Bonne G, Di Barletta MR, Varnous S, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nature Genet 1999; 21: 285-288.
54. Bione S, Maestrini E, Rivella S, et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nature Genet 1994; 8: 323-327.
55. Bonne G. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 2000; 48: 170-180.
56. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease. N Engl J Med 1999; 341: 1715-1724.
57. Muchir A, Bonne G, van der Kooi AJ, et al. Identification of mutations in the gene encoding lamin A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction distrubances (LGMDIB). Hum Mol Genet 2000; 9: 1453-1459.
58. Cao H, Hegele RA. Nuclear lamin A/C R428Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000; 9: 109-112.
59. Shackleton S, Lloyd DJ, Jackson SN, et al. LMNA encoding lamin A/C is mutated in partial lipodystrophy. Nature Genet 2000; 24: 153-156.
60. Novelli G, Muchir A, Sangiuolo F, et al. Mandibuloacral dysplasia is caused by mutations in LMNA-encoding lamin A/C. Am J Hum Genet 2002; 71: 426-431.
61. De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002; 70: 1075-1085.
62. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003; 423: 293-298.
63. De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin A truncation in Hutchinson-Gilford progeria Science 2003; 300 2055.
64. Chen L, Lee L, Kudlow BA, et al. LMNA mutations in atypical Werner's syndrome. Lancet 2003; 362: 440-445.
65. Ellis JA, Craxton M, Yates JR, Kendrick-Jones J. Aberrant intranuclear targeting and cell cycle-dependent phosphorylation of emerin contribute to Emery-Dreifuss muscular dystrophy phenotype. J Cell Sci 1998; 111: 781-792.
66. Fairley EA, Kendrick-Jones J, Ellis JA. The Emery-Dreifuss muscular dystrophy phenotype arises from aberrant targeting and binding of emerin at the inner nuclear membrane. J Cell Sci 1999; 112 2571-2582.
67. Vaughan OA, Alvarez-Reyes M, Bridger JM, et al. Lamins A and C form a structural complex that anchors emerin at the NE. J Cell Sci 2001; 114: 2577-2590.
68. Ostlund C, Bonne G, Schwartz K, Worman HJ. Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J Cell Sci 2001; 114: 4435-4445.
69. Raharjo WH, Enarson P, Sullivan T, Stewart CL, Burke B. Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J Cell Sci 2001; 114: 4447-4457.
70. Holt I, Clements L, Manilal S, Brown SC, Morris GE. The R428Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin. Eur J Hum Genet 2001; 9: 204-208.
71. Lloyd DJ, Trembath RC, Shackleton S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 2002; 11: 769-777.
72. Vigoroux C, Auclair M, Dubosclard E, et al. Nuclear disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. J Cell Sci 2001; 114: 4459-4468.
73. Agarwal AK, Fryns JP, Auchus RJ, Garg A. Zinc metalloproteinase, ZMPSTE24 is mutated in mandibuloacryl dysplasia. Hum Mol Genet 2003; 12: 1995-2001.
74. Goldman RD, Shumaker DK, Erdos MR, et al. Accumulation of mutant lamin A causes progessive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 2004; 101: 8963-8968.
75. Bridger JM, Kill IR. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol 2004; 39: 717-724.
76. Markiewicz E, Venables R, Alvarez-Reyes M, et al. Increased solubility of lamins and redistribution of lamin C in X-linked Emery-Dreifuss muscular dystrophy fibroblasts. J Struct Biol 2002; 140: 241-253.
77. Nikolova V, Leimena C, McMahon AC, et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 2004; 113: 357-369.
78. Lammerding J, Schulze PC, Takahashi T, et al. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 2004; 113: 370-378.
79. Broers JLV, Peeters EAG, Kuijpers HJH, et al. Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cyroskeletal integrity. Implications for the development of laminopathies. Hum Mol Genet 2004; 13(21): (in press).
80. Zhang Q, Skepper JN, Yang F, et al. Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues. J Cell Sci 2001; 114: 4485-4498.
81. Zhen Y-Y, Libotte T, Munck M, Noegal AA, Korenbaum E. NUANCE: a giant protein connecting the nucleus and actin cytoskeleton. J Cell Sci 2002; 115: 3207-3222.
82. Hutchison CJ. Lamins: building blocks or regulators of gene expression? Nature Rev Mol Cell Biol 2002; 3: 848-858.
83. Ozaki T, Saijo M, Murakami K, Enomoto H, Taya Y, Sakiyama S. Complex formation between lamin A and the retinoblastoma gene product: identification of the domain on lamin A required for its interaction. Oncogene 1994; 9: 2649-2653.
84. Markiewicz E, Dechat T, Foisner R, Quinlan RA, Hutchison CJ. Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein. Mol Biol Cell 2002; 13: 4401-4413.
85. Lloyd DJ, Trembath RC, Shackleton S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 2002; 11: 769-777.
86. Dreuillet C, Tillit J, Kress M, Ernoult-Lange M. In vivo and in vitro interaction between human transcription factor MOK2 and nuclear lamin A/C. Nucleic Acids Res 2002; 30: 4634-4642.
87. Holaska JM, Lee KK, Kowalski AK, Wilson KL. Transcription repressor germ cell-less (GCL) and barrier to autointegration factor (BAF) compete for binding to emerin in vitro. J Biol Chem 2003; 278: 6969-6975.
88. Johnson BR, Nitta RT, Frock RL, et al. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteosomal degradation. Proc Natl Acad U S A 2004; 101: 9677-9682.
89. Favreau C, Higuet D, Courvalin JC, Buendia B. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol Cell Biol 2004; 24: 1481-1492.
90. Markiewicz E, Ledran M, Hutchison CJ. Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro. J Cell Sci (in press).